Article Details

PCSK9 Inhibitors Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials ...

Retrieved on: 2023-11-21 17:16:26

Tags for this article:

Click the tags to see associated articles and topics

PCSK9 Inhibitors Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials .... View article details on HISWAI: https://www.digitaljournal.com/pr/news/getnews/pcsk9-inhibitors-pipeline-drugs-analysis-report-2023-fda-approvals-clinical-trials-therapies-moa-roa-by-delveinsight-novo-nordisk-astrazeneca-sirnaomics-vaxxinity-verve-therapeutics

Excerpt

AZD 8233: AstraZeneca; AK102: Akeso Biopharma; Evolocumab: Amgen; SHR-1209: Jiangsu Hengrui Medicine Co. Tafolecimab: Innovent Biologics; LIB003 ( ...

Article found on: www.digitaljournal.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up